专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

BRPI0402641A 未知
公开(公告)号：BRPI0402641A
公开(公告)日：2005-10-18
申请号：BRPI0402641
申请日：2004-02-26
申请人： SEO JEONG TAE , JUNG JUN HO , SOO CHO JANG , KIM JEONG HOON
发明人： SEO JEONG TAE , JUNG JUN HO , SOO CHO JANG , KIM JEONG HOON
IPC分类号： B44C5/00

2. 发明公开

KR20100044523A Caron tube heating unit having uni-directional terminal 审中-公开
标题翻译：具有单向端子的管道加热单元
公开(公告)号：KR20100044523A
公开(公告)日：2010-04-30
申请号：KR20080103689
申请日：2008-10-22
申请人： KIM JEONG HOON
发明人： KIM JEONG HOON
IPC分类号： H05B3/64
CPC分类号： H05B3/44 , H05B3/06 , H05B3/145 , H05B3/46 , H05B2203/016 , H05B2203/021
摘要： PURPOSE: A carbon heating element is provided to improve corrosion resistance and durability by forming a body and an insulation tube made of heat-resistance glass. CONSTITUTION: A carbon heating element is comprised of a carbon fiber(10) and a ground line(15). A carbon heating element comprises a body(20), an insulation tube(30) and a terminal(40). The body receives the carbon fiber and the ground line. The body is sealed by a tube part(22) and a plate part(24). The insulation tube receives the ground line. The carbon fiber surrounds the outer circumference of the insulation tube. The terminal is arranged on the plate of the body. The terminal connects the carbon fiber and the ground line.
摘要翻译：目的：提供碳加热元件，通过形成由耐热玻璃制成的主体和绝缘管来提高耐腐蚀性和耐久性。构成：碳加热元件由碳纤维（10）和接地线（15）构成。碳加热元件包括主体（20），绝缘管（30）和端子（40）。身体接收碳纤维和地线。主体由管部分（22）和板部分（24）密封。绝缘管接收地线。碳纤维围绕绝缘管的外周。终端设置在身体的板上。端子连接碳纤维和地线。

3. 发明公开

KR20200140564A 수면 유도 기기 审中-公开
公开(公告)号：KR20200140564A
公开(公告)日：2020-12-16
申请号：KR20190067349
申请日：2019-06-07
申请人： KIM JEONG HOON
发明人： KIM JEONG HOON
IPC分类号： A61M21/02 , A61F11/08 , A61M21/00
摘要： 본발명의일실시예는사용자의귀에삽입되고, 일측에는개방부와연통된삽입공간부가형성된케이스; 및외부에서발생되는소음을차단하는외부소음차단부가구비되고상기개방부를통해상기삽입공간부에결합되는본체부를포함하는수면유도기기를제공한다.

4. 发明申请

WO2011155797A3 HEMIOXALATE SALT OF CRYSTALLINE O-DESMETHYLVENLAFAXINE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION THEREOF 审中-公开
标题翻译：结晶O-脱乙酰壳多糖的羟甲酸盐，其制备方法及其药物组合物
公开(公告)号：WO2011155797A3
公开(公告)日：2012-05-03
申请号：PCT/KR2011004284
申请日：2011-06-10
申请人： DONG A PHARM CO LTD , PARK SANG-GOOK , LIM JOONG-IN , HAN SANG-DUG , MIN JONG-PIL , KIM JEONG-HOON , JANG SUN-WOO , HWANG HYUNG-DON , KIM SOON-HOE
发明人： PARK SANG-GOOK , LIM JOONG-IN , HAN SANG-DUG , MIN JONG-PIL , KIM JEONG-HOON , JANG SUN-WOO , HWANG HYUNG-DON , KIM SOON-HOE
IPC分类号： C07C215/64 , A61K31/135 , A61P25/24 , C07C55/06
CPC分类号： C07C55/06 , A61K31/135 , C07B2200/13 , C07C215/64 , C07C2601/14
摘要： The present invention relates to hemioxalate of crystalline O-desmethylvenlafaxine which maximizes solubility and has physicochemical properties of a solid material which is pharmaceutically preferable due to its non-hygroscopicity, to a preparation method of the hemioxalate, and to a pharmaceutical composition of the hemioxalate. The hemioxalate of crystalline O-desmethylvenlafaxine according to the present invention can: increase bioavailability of drugs due to its high solubility; allow various formulations to be very easily designed without composition size limitations; and administer high doses of drugs regardless of the dose-limiting volume of an animal. Thus, the hemioxalate of crystalline O-desmethylvenlafaxine facilitates the confirmation of expressible toxicity, and is suitable for distribution of raw materials and production of medicines because of low hygroscopicity.
摘要翻译：本发明涉及结晶性O-去甲基文拉法辛的半胱氨酸盐，其使溶解度最大并且由于其非吸湿性而药学上优选的固体物质具有物理化学性质，并且涉及半胱氨酸盐的制备方法和半胱氨酸盐的药物组合物。根据本发明的结晶O-去甲基文拉法新的hemioxalate可以：提高药物的高溶解度的生物利用度; 允许各种配方非常容易地设计而没有组成尺寸限制; 并施用高剂量的药物，而不管动物的剂量限制体积。因此，结晶O-去甲基文拉法辛的hemioxalate有助于确定可表达的毒性，适合于原料的分配和药物的生产，因为吸湿性低。

5. 发明申请

WO2010071320A3 CONTROLLED-RELEASE COMPOSITION FOR PRODUCING SUSTAINED-RELEASE PREPARATION CONTAINING UDENAFIL 审中-公开
标题翻译：用于生产含有UDENAFIL的持续释放制剂的控制释放组合物
公开(公告)号：WO2010071320A3
公开(公告)日：2010-09-30
申请号：PCT/KR2009007382
申请日：2009-12-10
申请人： DONG A PHARM CO LTD , YOO MOO-HI , CHA BONG-JIN , KIM JEONG-HOON , JANG SUN-WOO , HAN SANG-DUG
发明人： YOO MOO-HI , CHA BONG-JIN , KIM JEONG-HOON , JANG SUN-WOO , HAN SANG-DUG
IPC分类号： A61K47/48 , A61K9/22 , A61K31/519
CPC分类号： A61K31/519 , A61K9/2031 , A61K9/2054
摘要： The present invention relates to a controlled-release composition for producing a sustained-release preparation containing udenafil. More particularly, the present invention relates to a controlled-release composition for producing a sustained-release preparation containing udenafil, said composition comprising (A) udenafil and a pharmaceutically acceptable salt, (B) a solubility modulator, (C) an adsorbent, and (D) a hydrophilic polymer. The controlled-release composition for producing a sustained-release preparation containing udenafil according to the present invention releases drugs constantly regardless of the pH level in the gastrointestinal tract, and thus freely controls the drug release time within the range of 3 to 24 hours, and reduces the variability in the effect of drugs among individuals. In addition, the composition of the present invention can be produced into a sustained-release preparation which has an optimum condition for expressing the effect of drugs in the treatment of diseases such as pulmonary arterial hypertension, hepatic portal vein hypertension, benign prostatic hyperplasia, and the like, which can be treated by udenafil and which requires the administration of drugs over a long period of time. Further, the composition of the present invention can control the release of drugs in accordance with the time taken for the absorption thereof when said drugs are applied to a living body, and thus can be valuably used in preventing and treating erectile dysfunction.
摘要翻译：本发明涉及一种用于制备含有乌来萘非缓释制剂的控释组合物。更具体地说，本发明涉及一种用于制备含有乌来啡非的缓释制剂的控释组合物，所述组合物包含（A）胭脂红和药学上可接受的盐，（B）溶解性调节剂，（C）吸附剂，和（D）亲水性聚合物。本发明的含有乌来那非的缓释制剂的控释组合物不管胃肠道的pH值如何，均不断释放药物，因此可以将药物释放时间自由控制在3〜24小时的范围内，降低药物在个体间的作用的变异性。此外，本发明的组合物可以制成缓释制剂，其具有表达药物治疗肺动脉高压，肝门静脉高压，良性前列腺增生等疾病的效果的最佳条件，类似物，可以被乌多那非治疗，需要长时间的药物治疗。此外，本发明的组合物可以在将药物施用于生物体时根据吸收时间来控制药物的释放，因此可以有效地用于预防和治疗勃起功能障碍。

6. 发明申请

WO2010008224A3 FAST-DISSOLVING AMLODIPINE TABLETS OF IMPROVED STABILITY AND A METHOD OF MANUFACTURE THEREOF 审中-公开
标题翻译：改善稳定性的快速溶解的AMLODIPINE片剂及其制造方法
公开(公告)号：WO2010008224A3
公开(公告)日：2010-04-22
申请号：PCT/KR2009003931
申请日：2009-07-16
申请人： DONG A PHARM CO LTD , YOO MOO-HI , CHA BONG-JIN , KIM JEONG-HOON , JANG SUN-WOO , PARK CHAN-WOONG
发明人： YOO MOO-HI , CHA BONG-JIN , KIM JEONG-HOON , JANG SUN-WOO , PARK CHAN-WOONG
IPC分类号： A61K9/22 , A61K9/20 , A61K9/28 , A61K31/215 , A61K31/44
CPC分类号： A61K9/0056
摘要： The present invention relates to a method for manufacturing fast-dissolving amlodipine tablets having improved storage stability as a result of containing amlodipine or a pharmaceutically acceptable salt and having physicochemical stability. Fast-dissolving amlodipine tablets manufactured according to the present invention exhibit excellent results when evaluated in terms of appearance, content and impurities, and therefore have sufficient storage stability up to their expiration date, despite amlodipine's characteristic physicochemical instability in the presence of moisture. Said amlodipine tablets dissolve quickly in the mouth with no discomfort.
摘要翻译：本发明涉及由于含有氨氯地平或其药学上可接受的盐并具有物理化学稳定性而具有改善的储存稳定性的快速溶解氨氯地平片剂的方法。尽管在水分存在下氨氯地平特有的物理化学不稳定性，但根据本发明制造的快速溶解氨氯地平片剂在外观，含量和杂质方面评估时表现出优异的结果，并因此具有足够的储存稳定性直至其有效期。所述氨氯地平片在口中迅速溶解而没有不适。

7. 发明申请

WO2009008632A3 GASTRORETENTIVE SYSTEM CONTAINING SOLUBILIZED DRUG FOR MAXIMIZING ITS THERAPEUTIC EFFECT FOR GASTRITIS 审中-公开
公开(公告)号：WO2009008632A3
公开(公告)日：2009-01-15
申请号：PCT/KR2008/003950
申请日：2008-07-04
申请人： DONG-A PHARM. CO., LTD. , YOO, Moo-Hi , KIM, Jeong-Hoon , JANG, Sun-Woo , LEE, Jung-Woo , HAN, Sang-Dug , PARK, Sung-Hyun
发明人： YOO, Moo-Hi , KIM, Jeong-Hoon , JANG, Sun-Woo , LEE, Jung-Woo , HAN, Sang-Dug , PARK, Sung-Hyun
IPC分类号： A61K31/352
摘要： There is provided a gastroretentive system matrix formulation containing a compound represented by Formula 1 that has a therapeutic effect on gastritis and is solubilized in the stomach, and a method for preparing the gastroretentive system matrix formulation. The gastroretentive system matrix formulation according to the present invention may be useful to improve the solubility of a solubilized drug under an acidic condition in the stomach, and maximize an anti-inflammatory effect of the solubilized drug by increasing the retention time of the formulation in the stomach through the continuous release the solubilized drug into the stomach.

8. 发明申请

WO2007052954A1 BLOCK COPOLYMERS CONTAINING PERFLUOROCYCLOBUTANE RINGS AND ELECTROLYTE MEMBRANES USING THE SAME 审中-公开
标题翻译：含有全氟醚环的嵌段共聚物和使用其的电解质膜
公开(公告)号：WO2007052954A1
公开(公告)日：2007-05-10
申请号：PCT/KR2006/004513
申请日：2006-11-01
申请人： LG CHEM, LTD. , KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY , SHIN, Chong Kyu , LEE, Bong Keun , KIM, Jeong Hoon , CHANG, Bong Jun , LEE, Soo Bok , PARK, In Joon , KIM, Dong Kwon , LEE, Kwang Won , HA, Jong Wook , KIM, Kwang Han , KIM, Dong Jin , YOO, Min Chul
发明人： SHIN, Chong Kyu , LEE, Bong Keun , KIM, Jeong Hoon , CHANG, Bong Jun , LEE, Soo Bok , PARK, In Joon , KIM, Dong Kwon , LEE, Kwang Won , HA, Jong Wook , KIM, Kwang Han , KIM, Dong Jin , YOO, Min Chul
IPC分类号： C08G61/12 , C08J5/22
CPC分类号： C08G61/02
摘要： The present invention relates to a block copolymer comprising perfluorocyclobutane group, a process for preparing the same, and an electrolyte membrane comprising the same. The block copolymer comprising perfluorocyclobutane group according to the present invention can be easily prepared. And, the electrolyte membrane comprising the polymer has good proton conductivity and mechanical property; the distribution, position, and number of sulfonic acid group can be controlled, and the membrane properties are not decreased even though sulfonic acid group is increased. Thus, the present block copolymer can be used for a variety of membrane materials, especially electrolyte membrane of fuel cell.
摘要翻译：本发明涉及包含全氟环丁烷基团的嵌段共聚物，其制备方法和包含其的电解质膜。包含根据本发明的全氟环丁烷基的嵌段共聚物可以容易地制备。而且，包含聚合物的电解质膜具有良好的质子传导性和机械性能; 可以控制磺酸基的分布，位置和数量，即使磺酸基增加，膜性能也不会降低。因此，本发明的嵌段共聚物可用于各种膜材料，特别是燃料电池的电解质膜。

9. 发明申请

WO2006004358A1 DICOUMAROL-REMOVED EXTRACT OF ARTEMISIA, PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF 审中-公开
标题翻译：葡萄糖甙类去除提取物，其制备和药物组合物
公开(公告)号：WO2006004358A1
公开(公告)日：2006-01-12
申请号：PCT/KR2005/002095
申请日：2005-07-01
申请人： DONG-A PHARM. CO., LTD. , KIM, Jong Oh , OH, Tae Young , AHN, Byoung Ok , KIM, Jeong Hoon , KWON, Jong Won , KIM, Won Bae , CHOI, Seul Min , KANG, Kyung Ku
发明人： KIM, Jong Oh , OH, Tae Young , AHN, Byoung Ok , KIM, Jeong Hoon , KWON, Jong Won , KIM, Won Bae , CHOI, Seul Min , KANG, Kyung Ku
IPC分类号： A61K31/37
CPC分类号： A61K31/37 , A61K36/282
摘要： The present invention relates to an extract of Artemisia (A. asiatica, A. mongolica, A. princeps, and A. argyi) from which harmful ingredients showing blood coagulation inhibitory action were removed selectively without loss of eupatilin, jaceosidin and artemicapin C contents, a method to prepare said Artemisia extract, a therapeutic or preventive pharmaceutical composition for gastrointestinal disease containing said Artemisia extract as an effective ingredient, a therapeutic or preventive pharmaceutical composition for gastrointestinal disease containing artemicapin C of a constituent of said Artemisia extract as an effective ingredient, and a pharmaceutical composition of Artemisia extract comprising said Artemisia extract, surfactant and co-solvent.
摘要翻译：本发明涉及选择性除去显示凝血抑制作用的有害成分的艾蒿（A. asiatica，A.mongolica，A.peruncae，A.Argyi）的提取物，而不损失艾曲坦，菊酯和青蒿素C含量，一种制备所述艾蒿提取物的方法，含有所述青蒿提取物作为有效成分的用于胃肠疾病的治疗或预防药物组合物，含有所述艾蒿提取物的成分的青蒿素C作为有效成分的胃肠道疾病的治疗或预防药物组合物，以及含有所述蒿提取物，表面活性剂和助溶剂的蒿提取物的药物组合物。

10. 发明申请

WO2004063095A3 METHOD FOR PRODUCTION OF SOLVENT FOR HIGH SOLUTION OF CALCIUM, CALCIUM POWDER WITH HIGH SOLUBILITY THEREOF AND CALCIUM LIQUID THEREOF 审中-公开
标题翻译：用于生产高溶解度的溶剂的溶液的方法，具有高溶解度的钙粉和其液体
公开(公告)号：WO2004063095A3
公开(公告)日：2004-10-07
申请号：PCT/KR2004000031
申请日：2004-01-10
申请人： JEONG YONG-JIN , PARK NAN-YOUNG , KIM GYUNG-EUN , KEIMYUNG FOODEX CO LTD , KIM JEONG-HOON
发明人： JEONG YONG-JIN , PARK NAN-YOUNG , KIM GYUNG-EUN , KIM JEONG-HOON
IPC分类号： A23L1/304 , C01F11/00 , A23L1/00 , A23L1/30
CPC分类号： A23L33/16 , A23V2002/00 , A23V2250/022 , A23V2250/046 , A23V2250/042 , A23V2250/1578 , A23V2250/21
摘要： Disclosed is a method of preparing a solvent capable of enhancing solubility of calcium. In addition, the present invention discloses a method of preparing a calcium powder with enhanced solubility, based on the dissolution of calcium in the solvent, and a method of preparing a calcium liquid, based on the dissolution of the calcium powder in vinegar.
摘要翻译：公开了一种制备能够提高钙溶解度的溶剂的方法。此外，本发明公开了一种基于钙在溶剂中的溶解而制备具有增强的溶解度的钙粉的方法，以及基于钙粉溶解在醋中的钙液的制备方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式